Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...

The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of ...

ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Non-surgical weight loss treatments are becoming more accessible, effective, and more in tune with your body's natural ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.

Private equity firms are recalibrating their approach to physician practice acquisitions, seeking new avenues for growth and profitability in a shifting healthcare landscape, according to VMG Health’s ...

A study presented at ACC 2025 found that colchicine use in diabetic patients without CAD significantly reduced 3-year ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

After reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will ...

Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...